Blog barnaclínic


  1. 16 February, 2021

    The AEMPS approves the use of a CAR-T therapy developed by the Hospital Clínic Group for the treatment of a type of leukaemia

    CAR-T ARI-0001 Inmunoterapia contra la leucemia

    In recent years, cancer treatment has been revolutionised by immunotherapy, an approach that uses a patient’s own immune system to attack tumour cells. The Spanish Agency of Medicines and Medical Devices (AEMPS) has just approved ARI-0001, a CAR T-cell therapy (a type of immunotherapy) developed entirely by the Hospital Clínic Group, for use as a medicinal product. This is the first time that a treatment with genetically modified cells developed entirely in Europe has been approved by a regulatory agency, and it is also the first time that it has been done without the backing of a pharmaceutical company.

    Read more…

  2. 10 February, 2021

    A new molecular test detects genetic abnormalities in tumours and improves customised cancer diagnosis and treatment

    Test molecular diagnostico del cancer

    At the Grupo Hospital Clínic, we have a new option for diagnosis of advanced cancer. It is a new test using Next Generation Sequencing (NGS) technology which, by analysing the tumour’s DNA and RNA, detects multiple genetic abnormalities in 52 of your genes. This new cancer diagnostic test allows your treatment to be further customised. In addition, it improves current tests for the diagnosis of lung, colon and rectal cancer and melanoma.

    Read more…

  3. 14 October, 2020

    Three services of the Hospital Clínic among the best in the world in the ‘World’s Best Specialized Hospitals’

    The Hospital Clínic Group of Barcelona has had three of its Institutes included in the ‘World’s Best Specialized Hospitals‘; a classification that recognizes the best hospitals in the world by speciality. The Clinical Cardiovascular Institute (ICCV), led by Dr. Marta Sitges, the Clinical Institute of Digestive and Metabolic Diseases (ICMDM), directed by Dr. Josep Vidal, and the Institute of Hemato-oncological Diseases (ICMHO), with Dr. Álvaro Urbano-Ispizua at the helm, are among the best in the world in their respective specialities according to the list produced annually by Newsweek magazine.

    Read more…